Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate
A non-interventional study of people newly diagnosed with schizophrenia treated with paliperidone palmitate has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana [Phase 4]
A completed Phase 4 study evaluating how to integrate psychotropic medications into care for people with mental disorders at a prayer camp i…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia [Phase 3]
Phase 3 study evaluating three different doses of OPC-34712 in adults with acute schizophrenia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants [Phase 1]
Phase 1 pharmacokinetics study of five antipsychotic medications in psychiatric participants has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 1]
Phase 1 trial assessing the effects of OPC-34712 on QT/QTc in subjects with schizophrenia or schizoaffective disorder; results were posted i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Multicenter, Open-label, Safety and Tolerability Study [Phase 2]
Phase 2 multicenter open-label study evaluating safety and tolerability in schizophrenia; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects [Phase 1]
Phase 1 trial update of OPC-34712 evaluating safety in adults with normal renal function and renal impairment, including subjects with schiz…
-
CLINICAL_TRIALS research · 2015-10-27Clinical Trial Update: The Neural Bases of Early Visual and Auditory Processing and Emotion Recognition Deficits in Schizophrenia
Clinical trial update investigating neural bases of early visual and auditory processing and emotion recognition deficits in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: Acute Glycine Pharmacodynamic Study [NA]
A completed clinical trial studied acute glycine pharmacodynamics in schizophrenia and related psychotic disorders; results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581 [Phase 1]
A Phase 1 single-ascending-dose study with a food-effect cohort evaluated AMG 581 in patients with schizophrenia or schizoaffective disorder…
-
FDA approval · 2015-10-22FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for Risperidone from Jubilant Cadista Pharmaceuticals Inc., signifying an approval related to this g…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Antipsychotics and Risk of Hyperglycemic Emergencies
A completed clinical trial update examining whether antipsychotics are associated with an elevated risk of hyperglycemic emergencies in peop…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Clinical Registry of Patients Under Treatment With Atypical Antipsychotics
A clinical trial registry study of patients treated with atypical antipsychotics has completed enrollment and is reporting on outcomes acros…
-
FDA approval · 2015-10-20FDA Approved: OLANZAPINE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's original application to manufacture and market a generic olanzapine product.
-
CLINICAL_TRIALS research · 2015-10-16Clinical Trial Update: Electroconvulsive Therapy in Clozapine-resistant Schizophrenia [NA]
Clinical trial update on using electroconvulsive therapy for clozapine-resistant schizophrenia, covering schizophrenia and schizoaffective d…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Electroconvulsive Therapy in Clozapine Refractory Schizophrenia [Phase 1, Phase 2]
A Phase 1/2 trial evaluates electroconvulsive therapy for schizophrenia patients refractory to clozapine, with results posted in 2015.
-
CLINICAL_TRIALS withdrawal · 2015-10-12Clinical Trial Update: Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia [Phase 2]
A Phase 2 trial evaluating targeted Vitamin D treatment for schizophrenia-associated hyperprolinemia has been withdrawn.
-
FDA approval · 2015-10-08FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA has approved a supplemental application for Clozaril (clozapine) filed by HLS Therapeutics (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: An Open-Label Trial of Tocilizumab in Schizophrenia [Phase 1]
Open-label Phase 1 trial of tocilizumab in schizophrenia has completed; results were posted in 2015.
-
FDA approval · 2015-10-05FDA Approved: ARISTADA — Original Application (Alkermes, Inc.)
FDA approved Aristada (aripiprazole lauroxil) through Alkermes' Original Application, introducing a long-acting injectable antipsychotic. It…
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia [NA]
A completed clinical trial evaluated strategies to improve adherence to oral antipsychotic medications in people with schizophrenia or schiz…
-
FDA approval · 2015-09-30FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for VERSACLOZ (clozapine) submitted by TruPharma LLC.
-
FDA approval · 2015-09-30FDA Approved: ARIPIPRAZOLE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s Original Application for aripiprazole, granting approval of a generic version of the antipsychotic.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Acute Effects of Exercise in Smokers With Schizophrenia [Phase 2]
A Phase 2 trial from Brown University evaluated the acute effects of exercise on tobacco dependence and cigarette craving in smokers with sc…
-
FDA approval · 2015-09-24FDA Approved: PALIPERIDONE — Original Application (Archis Pharma LLC)
FDA approved Archis Pharma LLC's paliperidone original application, authorizing a generic paliperidone product. Paliperidone is used to trea…